RecruitingNot ApplicableNCT06263907
Stellate Ganglion Block for Prevention of Post Mastectomy Depression
Preemptive Efficacy of Stellate Ganglion Block for Prevention of Post Mastectomy Depression
Sponsor
Mansoura University
Enrollment
140 participants
Start Date
Mar 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Complications after mastectomy include chronic pain and depression.
Eligibility
Sex: FEMALEMin Age: 21 YearsMax Age: 65 Years
Inclusion Criteria5
- Female patients
- Age ranging from 18 to 65 years
- American Society of Anesthesiologists (ASA) no more than II
- Had unilateral cancer breast
- Scheduled to do unilateral modified radical mastectomy
Exclusion Criteria10
- Pregnant female
- Existing Horner syndrome
- Had any neuromuscular disease
- Had allergy to local anesthetics
- History of use of analgesics
- Had any deformity or a previous surgery in the neck or ipsilateral arm or breast
- Had any contraindication to the procedure (coagulation disorders, local infection, sepsis)
- Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders)
- History of psychotic disorder including depression, bipolar disorder or personality disorder
- Patient with Beck Depression Inventory (BDI) score more than 13
Interventions
PROCEDUREStellate gangalion block
The efficacy of Preoperative ipsilateral stellate gangalion block on the occurrence of postmastectomy depression and pain compared with no block
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06263907
Related Trials
Interoceptive Awareness and Function in Adolescents With Chronic Pain
NCT073251101 location
Evaluating the Efficacy of the Pain Identification and Communication Toolkit
NCT061686041 location
A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors
NCT070718962 locations
Diabetic Neuropathy in Spinal Cord Stimulator Patients
NCT046872151 location
Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)
NCT073624852 locations